We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales

    Background

    Medications with anticholinergic effects are commonly used in nursing homes, and their cumulative effect is of particular concern for the...

    Alessio Novella, Chiara Elli, ... Luca Pasina in Drugs & Aging
    Article 24 August 2023
  2. Development of the Swedish anticholinergic burden scale (Swe-ABS)

    Background

    Drugs with anticholinergic properties are associated with cognitive adverse effects, especially in patients vulnerable to central...

    Tanja Rube, Astrid Ecorcheville, ... Per Johansson in BMC Geriatrics
    Article Open access 25 August 2023
  3. Low-Income Older Adults’ Vulnerability to Anticholinergic Medication-Associated Frailty

    Background

    A growing body of research supports the negative impact of anticholinergic drug burden on physical frailty. However, prior research has...

    Lana Sargent, Kristin M. Zimmerman, ... Elvin T. Price in Drugs & Aging
    Article 19 October 2023
  4. Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer’s Disease Initiating Cholinesterase Inhibitors

    Background

    Cumulative anticholinergic burden refers to the cumulative effect of multiple medications with anticholinergic properties. However,...

    Ashna Talwar, Satabdi Chatterjee, ... Rajender R. Aparasu in Drugs & Aging
    Article 11 March 2024
  5. Development and Pilot Testing of an Algorithm-Based Approach to Anticholinergic Deprescribing in Older Patients

    Background

    Adverse anticholinergic drug reactions are common, yet evidence on how to reduce exposure to anticholinergic activity and reliably measure...

    Tanja Wehran, Annette Eidam, ... Hanna Marita Seidling in Drugs & Aging
    Article Open access 06 February 2024
  6. The relationship between dry eye disease and anticholinergic burden

    Purpose

    Anticholinergic drugs are widely prescribed for many medical conditions. However, data on the association of anticholinergic burden with dry...

    Zeynep Katipoğlu, Rafiye Nur Abay in Eye
    Article 09 February 2023
  7. The Prognostic Utility of Anticholinergic Burden Scales: An Integrative Review and Gap Analysis

    Background

    Anticholinergic drugs are commonly prescribed, especially to older adults. Anticholinergic burden scales (ABS) have been used to evaluate...

    Henry Ukachukwu Michael, Okechukwu Enechukwu, ... Nancy E. Mayo in Drugs & Aging
    Article 18 July 2023
  8. Clinical pharmacist-led assessment and management of anticholinergic burden and fall risk in geriatric patients

    Background

    The aim of this study was to examine the risk of fall with the surrogate outcome of the Aachen Falls Prevention Scale and to assess the...

    Hilal Gökçay Saz, Nadir Yalçın, ... Meltem Gülhan Halil in BMC Geriatrics
    Article Open access 15 December 2023
  9. Associations Between Midlife Anticholinergic Medication Use and Subsequent Cognitive Decline: A British Birth Cohort Study

    Background

    Anticholinergic medication use is associated with cognitive decline and incident dementia. Our study, a prospective birth cohort analysis,...

    Mark J. Rawle, Wallis C. Y. Lau, ... Daniel Davis in Drugs & Aging
    Article 13 May 2024
  10. An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders

    Drug-induced movement disorders (DIMDs) are associated with use of dopamine receptor blocking agents (DRBAs), including antipsychotics. The most...

    Nora Vanegas-Arroyave, Stanley N. Caroff, ... Samantha A. Cicero in CNS Drugs
    Article Open access 19 March 2024
  11. Anticholinergic Use for OAB in the Older Woman: An Update

    Purpose

    This expert narrative review discusses the role of anticholinergic therapy for overactive bladder in older women with a focus on recent...

    Berkley Davis, Katherina Chen, ... Jacqueline Zillioux in Current Geriatrics Reports
    Article 01 March 2023
  12. Disentangling drug contributions: anticholinergic burden in older adults linked to individual medications: a cross-sectional population-based study

    Background

    Medications with potent anticholinergic properties have well-documented adverse effects. A high cumulative anticholinergic burden may arise...

    Gauri Bhatkhande, Niteesh K. Choudhry, ... Julie C. Lauffenburger in BMC Geriatrics
    Article Open access 10 January 2024
  13. Exploring the impact of anticholinergic burden on urinary independence: insights from a post-stroke cohort of older adults

    Background

    Anticholinergic burden is associated with adverse events in the older adults. However, there is a lack of evidence regarding its effect on...

    Ayaka Matsumoto, Yoshihiro Yoshimura, ... Kenichiro Maekawa in International Journal of Clinical Pharmacy
    Article 18 April 2024
  14. The association between anticholinergic burden and mobility: a systematic review and meta-analyses

    Background

    As people age, they accumulate several health conditions, requiring the use of multiple medications (polypharmacy) to treat them. One of...

    Geofrey O. Phutietsile, Nikoletta Fotaki, ... Prasad S. Nishtala in BMC Geriatrics
    Article Open access 22 March 2023
  15. Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review

    Anticholinergics have been used in the treatment of overactive bladder (OAB), but their use is limited by poor tolerability and...

    Roger R. Dmochowski, Diane K. Newman, ... A. Lenore Ackerman in Advances in Therapy
    Article Open access 19 September 2023
  16. Anticholinergic Burden in Patients Treated for Overactive Bladder: Second-Line Therapy with Tibial Nerve Stimulation as a Solution

    Overactive bladder (OAB) is a highly prevalent condition with significant associated comorbidities. Current management guidelines suggest the...

    Nihal Satyadev, Maryam Ameen, ... Hsin Wang in International Urogynecology Journal
    Article 03 May 2024
  17. Seminal papers in urology: anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence

    In this critical review, we explore the study design, strengths, and limitations of landmark trial “Anticholinergic therapy vs. onabotulinumtoxinA...

    Nathan Shugg, Michael E. O’Callaghan in BMC Urology
    Article Open access 24 May 2023
  18. Overactive Bladder Medication Prescribing Trends in the Era of Known Cognitive Effects from Anticholinergic Drugs

    Purpose of Review

    To review recent global trends in the prescribing of anticholinergic medications for overactive bladder (OAB) and the potential...

    Noah Stern, Blayne Welk in Current Bladder Dysfunction Reports
    Article 04 August 2023
  19. Anticholinergic drugs for parkinsonism and other movement disorders

    Anticholinergic (AC) drugs, a medication class that acts by blocking nicotinic and muscarinic acetylcholine receptors, were first utilized for...

    Peter A. LeWitt, Luke Hong, Mark S. Moehle in Journal of Neural Transmission
    Article 21 June 2024
  20. Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia

    Background

    Patients with psychosis frequently use a variety of psychotropic medicines, many of which have anticholinergic effects that can impair...

    Chadia Haddad, Pascale Salameh, ... Benjamin Calvet in BMC Psychiatry
    Article Open access 24 January 2023
Did you find what you were looking for? Share feedback.